Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study

Published:2016-03-02 Issue:9 Volume:43 Page:1638-1645
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Hyun Seung Hyup,Eo Jae Seon,Lee Jeong Won,Choi Joon Young,Lee Kyung-Han,Na Sae Jung,Hong Il Ki,Oh Jin Kyoung,Chung Yong An,Song Bong-Il,Kim Tae-Sung,Kim Kyung Sik,Moon Dae Hyuk,Yun Mijin

Funder

Korean Society of Nuclear Medicine

Korea University

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-016-3348-y.pdf

Reference22 articles.

1. European Association for The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.

2. Bargellini I, Sacco R, Bozzi E, Bertini M, Ginanni B, Romano A, et al. Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. Eur J Radiol. 2012;81:1173–8.